statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.087
CN - Cina	421
SG - Singapore	182
SE - Svezia	99
IT - Italia	90
KR - Corea	68
HK - Hong Kong	58
UA - Ucraina	56
DE - Germania	55
VN - Vietnam	46
BR - Brasile	41
BG - Bulgaria	34
CA - Canada	32
CH - Svizzera	26
GB - Regno Unito	26
FR - Francia	25
FI - Finlandia	23
CI - Costa d'Avorio	14
IN - India	14
TR - Turchia	14
RU - Federazione Russa	13
BE - Belgio	11
NG - Nigeria	7
SN - Senegal	7
BD - Bangladesh	3
JO - Giordania	3
AM - Armenia	2
CL - Cile	2
IQ - Iraq	2
JP - Giappone	2
LT - Lituania	2
NL - Olanda	2
OM - Oman	2
PH - Filippine	2
RO - Romania	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AR - Argentina	1
AT - Austria	1
AU - Australia	1
ES - Italia	1
GE - Georgia	1
GH - Ghana	1
GT - Guatemala	1
HN - Honduras	1
ID - Indonesia	1
JM - Giamaica	1
KG - Kirghizistan	1
LV - Lettonia	1
MA - Marocco	1
MX - Messico	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PK - Pakistan	1
PL - Polonia	1
PT - Portogallo	1
PY - Paraguay	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
ZA - Sudafrica	1
Totale	2.499

Nome	#
Antibodies against hepatitis C virus in mixed cryoglobulinemia patients.	330
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.	234
Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda.	192
Low-antigen-content diet in the treatment of patients with IgA nephropathy	192
Hepatitis C virus, autoimmune liver disease and cryoglobulinaemic hepatitis.	182
Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia.	179
Hepatitis C virus and mixed cryoglobulinaemia.	160
Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas.	159
Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial.	153
Alpha interferon in the treatment of mixed cryoglobulinaemia patients.	151
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia.	150
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.	147
Association between hepatitis C virus and mixed cryoglobulinemia	144
Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia.	137
Totale	2.510

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	48	0	0	0	0	0	0	0	0	0	21	9	18
2021/2022	156	4	5	1	20	31	21	3	6	15	8	3	39
2022/2023	282	16	52	17	25	36	38	2	31	51	0	11	3
2023/2024	137	31	16	33	2	16	18	0	0	2	1	1	17
2024/2025	662	0	16	0	12	52	41	221	4	31	58	99	128
2025/2026	483	36	103	58	24	57	34	111	21	23	16	0	0
Totale													2.510

CINECA IRIS Institutional Research Information System